Solventum Corporation (SOLV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Solventum Corporation (SOLV)
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Key Insights
Critical company metrics and information
Share Price
$69.96Market Cap
$12.09 BillionTotal Outstanding Shares
172.76 Million SharesTotal Employees
22,000Dividend
No dividendIPO Date
March 26, 2024SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.3m.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow | $-126.00 Million |
Net Cash Flow From Financing Activities | $-202.00 Million |
Net Cash Flow From Investing Activities | $-93.00 Million |
Net Cash Flow, Continuing | $-126.00 Million |
Net Cash Flow From Investing Activities, Continuing | $-93.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-202.00 Million |
Net Cash Flow From Operating Activities, Continuing | $169.00 Million |
Net Cash Flow From Operating Activities | $169.00 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Operating Expenses | $890.00 Million |
Basic Earnings Per Share | $0.70 |
Gross Profit | $1.17 Billion |
Costs And Expenses | $1.81 Billion |
Diluted Average Shares | $173.90 Million |
Benefits Costs and Expenses | $1.92 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $122.00 Million |
Net Income/Loss | $122.00 Million |
Net Income/Loss Attributable To Parent | $122.00 Million |
Income Tax Expense/Benefit, Deferred | $-37.00 Million |
Revenues | $2.08 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income/Loss From Continuing Operations Before Tax | $167.00 Million |
Income Tax Expense/Benefit | $45.00 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Diluted Earnings Per Share | $0.70 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Selling, General, and Administrative Expenses | $701.00 Million |
Research and Development | $189.00 Million |
Cost Of Revenue | $917.00 Million |
Income/Loss From Continuing Operations After Tax | $122.00 Million |
Basic Average Shares | $173.40 Million |
Operating Income/Loss | $275.00 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Other Non-current Liabilities | $540.00 Million |
Other Non-current Assets | $7.14 Billion |
Inventory | $953.00 Million |
Accounts Payable | $560.00 Million |
Noncurrent Assets | $11.39 Billion |
Equity | $3.19 Billion |
Long-term Debt | $8.11 Billion |
Current Assets | $3.35 Billion |
Current Liabilities | $2.90 Billion |
Liabilities And Equity | $14.74 Billion |
Assets | $14.74 Billion |
Liabilities | $11.55 Billion |
Fixed Assets | $1.60 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Wages | $251.00 Million |
Noncurrent Liabilities | $8.65 Billion |
Intangible Assets | $2.65 Billion |
Other Current Liabilities | $2.09 Billion |
Equity Attributable To Parent | $3.19 Billion |
Other Current Assets | $2.40 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.